Publicações

AddThis Social Bookmark Button
2014

1. Alves M, Reinach P, Paula JS, Vellasco e Cruz AA, Bachette L, Faustino J, Aranha, Francisco JP, Vigorito AC, De Souza CA. Rocha EM. Comparision of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS One. 2014 May 21;9(5):e97921. doi: 10.1371/journal.pone.0097921. eCollection 2014.

2. Arnoni CP, Gazito D, Muniz JG, de Medeiros Person R, Brandão F, de Araújo Marques MG, Barreto JA, Castilho L, Latini FR. Two novel KEL alleles encoding K0 phenotypes in Brazilians.Transfusion. 2014 Feb 8. doi: 10.1111/trf.12564. [Epub ahead of print] No abstract available.

3. Arnoni CP, Latini FR, Muniz JG, Gazito D, Person Rde M, de Paula Vendrame TA, Barreto JA, Castilho L.How do we identify RHD variants using a practical molecular approach?Transfusion. 2014 Apr;54(4):962-9. doi: 10.1111/trf.12557. Epub 2014 Feb 28.

4. Baleotti W Jr, Ruiz MO, Fabron A Jr, Castilho L, Giuliatti S, Donadi EA. HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population. Transfusion. 2014 Apr 14. doi: 10.1111/trf.12652. [Epub ahead of print]

5. Barjas-Castro ML, Vigorito AC, Moretto FA, Castro V. Unusual Erythrocyte Split Chimerism in Pregnancy Following Allogenic Stem Cell Transplantation” submitted to Immunohematology (February/ 2014).

6. Benevides TCL, Orsi FA, Percout PO, Moura MS, Dias MA, Lins BD, De Paula EV, Vassalo J, Annichino-Bizzacchi JM. Acquired thrombotic thrombocytopenic púrpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman´s disease: a case report. Platelets. 2014 May 22:1-4. [Epub ahead of print]

7. Benites BD, Gilli SCO, Olalla Saad ST. Obesity, inflammation and their effects on the hematopoietic system. Revista Brasileira de Hematologia e Hemoterapia. 36(2), 147-151, 2014.

8. Brito AB, Lourenço GJ, Oliveira GB, De Souza CA, Vassallo J, Lima CS. Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma. Ann Hematol. 2014 Aug;93(8):1363-9. doi: 10.1007/s00277-014-2062-8. Epub 2014 Apr 1.

9. Brito, ABC, Reis F, De Souza CA, Vassallo JV, Lima CSP. Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy. Int J Clin Exp. Med 7(2):456-460, 2014.

10. Cabral-Marques O, Klaver S, Schimke LF, Ascendino EH, Khan TA, Pereira PV, Falcai A, Vargas-Hernández A, Santos-Argumedo L, Bezrodnik L, Moreira I, Seminario G, Di Giovanni D, Raccio AG, Porras O, Weber CW, Ferreira JF, Tavares FS, de Carvalho E, Valente CF, Kuntze G, Galicchio M, King A, Rosário-Filho NA, Grota MB, Dos Santos Vilela MM, Di Gesu RS, Lima S, de Souza Moura L, Talesnik E, Mansour E, Roxo-Junior P, Aldave JC, Goudouris E, Pinto-Mariz F, Berrón-Ruiz L, Staines-Boone T, Calderón WO, Del Carmen Zarate-Hernández M, Grumach AS, Sorensen R, Durandy A, Torgerson TR, Carvalho BT, Espinosa-Rosales F, Ochs HD, Condino-Neto A. First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes. J Clin Immunol. Feb;34(2):146-156, 2014

11. Conran, N.Intravascular Hemolysis: A Disease Mechanism Not to be Ignored. Acta Haematologica, 132:97 - 99, 2014.

12. Conti F, Bertrand G, Dezan M, Costa T, Aravechia M, Mota M, Castilho L, Kaplan C, Kutner J. Molecular HPA genotyping by microarray in Brazilian blood donors. Transfusion. 2013 Jun 13. doi: 10.1111/trf.12272. [Epub ahead of print]

13. da Silva RR, Pereira MC, Melo Rêgo MJ, Domingues Hatzlhofer BL, da Silva Araújo A, Cavalcanti Bezerra MA, da Rocha Pitta I, da Rocha Pitta MG.Evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers.Cytokine. Feb;65(2):143-147,2014. doi: 10.1016/j.cyto.2013.11.012.

14. De Camargo Moraes P, Silva CA, Soares AB, Passador-Santos F, Corrêa ME, de Araújo NS, de Araújo VC. Tooth alterations in areas of bisphosphonate-induced osteonecrosis. Clin Oral Investig. 2014 Jun 20. [Epub ahead of print]

15. De Souza CA. Five years of implementation of guidelines in hematology and transfusion medicine in Brazil. Rev Bras Hematol Hemoter. 2014 May-Jun;36(3):165-6. doi: 10.1016/j.bjhh.2014.03.022. Epub 2014 Apr 13. No

16.   De Souza CA. Randomized physiotherapy study to evaluate respiratory conditions in early phase of Hematopoietic Stem Cell Transplantation .BMT, 2013.

17.   Domingos IF, Falcão DA, Hatzlhofer BL, Cunha AF, Santos MN, Albuquerque DM, Fertrin KY, Costa FF, Azevedo RC, Machado CG, Araújo AS, Lucena-Araujo AR, Bezerra MA. Influence of the β(s) haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia. Ann Hematol. 2014 Jul;93(7):1123-9. doi: 10.1007/s00277-014-2016-1. Epub 2014 Feb 4.

18.   Dulley FL, Coracin FL, Saboya R, Massad E, Barros JCA, Nicolau JE, Cortez, AJP, Barban A, Vigorito AC, Miranda ECM, Aranha FJP, Ruiz MA, Mehta J, De Souza CA. “Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic boné marrow transplantation to reduce rejection (analysis of 178 patients, 22 years of follow-up”. RBHH, 2013.

19.   Fernandes MP, Leite AC, Araújo FF, Saad ST, Baratti MO, Correia MT, Coelho LC, Gadelha FR, Vercesi AE. The Cratylia mollis Seed Lectin Induces Membrane Permeability Transition in Isolated Rat Liver Mitochondria and a Cyclosporine A-Insensitive Permeability Transition in Trypanosoma cruzi Mitochondria.J Eukaryot Microbiol. 2014 May 6. doi: 10.1111/jeu.12118. [Epub ahead of print]

20. Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15. Am J Hematol. Apr;89(4):385-390, 2014.

21. Flores-Nascimento M, Kleinleider-Fontanesi K, Araujo TM, Anhe GF, Secolin R, Orsi FA, De Paula EV, Annichino-Bizzacchi Jm. Metabolic and inflammatory proteins differentially expressed in platelets from unprovoked deep vein thrombosis patients. J Proteomics Bioinform, 7:017-022, 2014.

22.  Gilli SC, Oliveira SA, Saad ST.Autologous Platelet Gel: Five Cases Illustrating Use on Sickle Cell Disease Ulcers. Int J Low Extrem Wounds. 3(2):120-126, 2014.

23. Gomes AO, Torres SR, Maiolino A, Dos Santos CW, Silva Junior A, Correa ME, Moreira MC, Gonçalves Lde S. Early and late oral features of chronic graft-versus-host disease. Rev Bras Hematol Hemoter. 36(1):43-49, 2014. doi: 10.5581/1516-8484.20140012.

24. Gomez K, Klamroth R, Mahlangu J, Mancuso ME, Mingot ME, Ozelo MC. Key issues in inhibitor management in patients with haemophilia.Blood Transfus. s319-s329, 2014. doi: 10.2450/2013.0246-12.

25. Guelsin GAS, Rodrigues C, Visentainer JEL, de Melo Campos P, Traina F, Gilli SCO, Olalla Saad ST, Castilho L. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome. Blood Transfusion, 2014. [epub ahead of print].

26. Hirata FE, Vasconcellos JP, Medina FM, Rim PH, Fulco EA, Melo MB. Association of LOC387715/ARMS2 (rs10490924) Gene Polymorphism with Age-related Macular Degeneration in the Brazilian Population. Ophthalmic Genet. 2013 Dec 30. [Epub ahead of print].

27. Holanda K, Lucena-Araujo AR, Quintas A, Mendonça T, Lima A, Vasconcelos LR, Moura P, Cavalcanti M, Machado C, Araújo AS, Bezerra MA. Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infections in chronic lymphocytic leukemia patients.Rev Bras Hematol Hemoter.36(1):29-34, 2014. doi: 10.5581/1516-8484.20140010.

28. Hughes TP, Saglio G, Kantarjian HM, Guilhot F, Niederwieser D, Rosti G, Nakaseko C, De Souza CA, Kalaycio ME, Meier S, Fan X, Menssen HD, Larson RA, Hochhaus A Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Blood. 27;123(9):1353-60. 2014. doi: 10.1182/blood-2013-06-510396.

29. Ikoma MR, Sandes AF, Thiago LS, Cavalcanti Júnior GB, Lorand-Metze IG, Costa ES, Pimenta G, Santos-Silva MC, Bacal NS, Yamamoto M, Souto EX; on behalf of GBCFLUX. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX. Cytometry B Clin Cytom. 2014 Apr 19. doi: 10.1002/cyto.b.21175. [Epub ahead of print]

30. Lasalde C, Rivera AV, León AJ, González-Feliciano JA, Estrella LA, Rodríguez-Cruz EN, Correa ME, Cajigas IJ, Bracho DP, Vega IE, Wilkinson MF, González CI. Identification and functional analysis of novel phosphorylation sites in the RNA surveillance protein Upf1.Nucleic Acids Res. Feb;42(3):1916-1929, 2014.

31. Lopes FC, Ferreira R, Albuquerque DM, Silveira AA, Costa R, Soares R, Costa FF, Conran N. In vitro and in vivo anti-angiogenic effects of hydroxyurea. Microvasc Res.2014 Jun 9;94C:106-113. doi: 10.1016/j.mvr.2014.05.009. [Epub ahead of print]

32. Luzo ACM. Fibrin Network Architectures in Pure Platelet-Rich Plasma as Characterized by Fiber Radius and Correlated with Clotting Time journal of Materials Science: Materials in Medicine (JMSM). Aceito

33. Machado Neto JA, De Melo Campos P, Olalla Saad ST, Traina F. YAP1 expression in Myelodysplastic syndromes and acute leukemias. Leuimia and Lymphoma, 2014 [epub ahead of print].

34. Machado Neto JA, Olalla Saad ST, Traina F. Stathmin 1 in normal and malignant hematopoiesis. BMB Reports, 2014. [epu ahead of print]

35. Machado-Neto JA, de Melo Campos P, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Olalla Saad ST, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leuk Res. 38(2):251-257, 2014.

36. Machado-Neto JA, Lazarini M, Favaro P, Franchi GC Jr, Nowill AE, Saad ST, Traina F. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.Exp Cell Res. 324:137-145, 2014 Apr 12. pii: S0014-4827(14)00150-5. doi: 10.1016/j.yexcr.2014.04.004.

37. Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators.Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.Blood. Jan 16;123(3):317-325, 2014. doi: 10.1182/blood-2013-10-529974.

38. Mascarenhas CD, Ferreira da Cunha A, Brugnerotto AF, Gambero S, de Almeida MH, Carazzolle MF, Pagnano KB, Traina F, Costa FF, de Souza CA. Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.Leuk Lymphoma. 2014 Feb 4. [Epub ahead of print]

39. Mazzucchelli JT, Bonfim C, Castro GG, Condino-Neto AA, Costa NM, Cunha L, Dantas EO, Dantas VM, de Moraes-Pinto MI, Fernandes JF, Goes HC, Goudouris E, Grumach AS, Guirau LM, Kuntze G, Mallozzi MC, Monteiro FP, Moraes LS, Nudelman V, Pinto JA, Rizzo MC, Porto-Neto AC, Roxo-Junior P, Ruiz M, Rullo VE, Seber A, Takano OA, Tavares FS, Toledo E, Vilela MM, Costa-Carvalho BT. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol. 2014;24(3):184-91.

40. Melo Rde C, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, de Melo Campos P, Saad ST. CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12.PLoS One. 2014 Jan 31;9(1):e85926.

41. Noce CW, Gomes A, Shcaira V, Corrêa ME, Moreira MC, Silva Júnior A, Gonçalves LS, Garnica M, Maiolino A, Torres SR. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014 Aug;20(8):1163-8. doi: 10.1016/j.bbmt.2014.04.009. Epub 2014 Apr 13.

42. Nucci M, Marr KA, Vehreschild MJ, Souza CA, Velasco E, Cappellano P, Carlesse F, Queiroz-Telles F, Sheppard DC, Kindo A, Cesaro S, Hamerschlak N, Solza C, Heinz WJ, Schaller M, Atalla A, Arikan-Akdagli S, Bertz H, Castro CG Jr, Herbrecht R, Hoenigl M, Härter G, Hermansen NE, Josting A, Pagano L, Salles MJ, Mossad SB, Ogunc Pasqualotto D, Araujo AC, V, Troke PF, Lortholary O, Cornely O,Anaissie E. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2013 Oct 1. doi: 10.1111/1469-0691.12409. [Epub ahead of print]

43. Orsi FA, Angerami RN, Mazetto BM, Quaino SK, De Paula EV, Annichino-Bizzachi JM. Bleeding complications in dengue are not associated with significant changes in the modulators of the endothelial barrier. J Infect Dev Ctries. 2014 Jun 11;8(6):799-803. doi: 10.3855/jidc.4542.

44. Ozelo MC, Vidal B, Brown C, Notley C, Hegadorn C, Webster S, Harpell L, Ahlin J, Winterborn A, Handforth J, Arruda VR, Hough C, Lillicrap D.Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response. Blood. 2014 Jun 26;123(26):4045-53. doi: 10.1182/blood-2013-12-545780. Epub 2014 May 14.

45. Ozelo MC, Villaça PR, Pérez-Bianco R, Candela M, Garcia-Chavez J, Moreno-Rodriguez B, Rodrigues MB, Rodriguez-Grecco I, Solano MH, Chumpitaz G, Morales-Gana MM, Ruiz-Sáez A. Musculoskeletal evaluation in severe haemophilia A patients from Latin America.Haemophilia. Jan;20(1):e63-70, 2014. doi: 10.1111/hae.12316.

46.   Pagnano KBB, Bendit I, Boquimpani C, De Souza CA, Mirand ECM, Larripa I, Nardinelli L, Silveira RA, Zalcberg I, Fogliatto L, Funke V, Pasquini R, Hungria V, Chiattone CS, Clementino N,Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlosvsky M, Cervera EE, Meillon LA, Simões BP, Spector N, Hamerschlak N, Bozzano AHM, Mayta EAF, Cortes J, Bengio RM. BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors – impact on survival – a study on behalf of Latin American Leukemia Net. Hematol, in press.

47. Pallis FR, Conran N, Fertrin KY, Olalla Saad ST, Costa FF, Franco-Penteado CF. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients. Br J Haematol. 164(2):286-295, 2014. doi: 10.1111/bjh.12628.

48. Peretti de Albuquerque Wobeto V, Machado-Neto JA, Zaccariotto TR, Ribeiro DM, da Silva Santos Duarte A, Saad ST, Costa FF, de Fatima Sonati M . PIPKIIαis widely expressed in hematopoietic-derived cells and may play a role in the expression of alpha- and gamma-globins in K562 cells.Mol Cell Biochem. 393:145-153, 2014.

49. Perez AG, Lana JF, Rodrigues AA, Luzo AC, Belangero WD, Santana MH.Relevant aspects of centrifugation step in the preparation of platelet-rich plasma.ISRN Hematol. 2014 Mar 25;2014:176060. doi: 10.1155/2014/176060. eCollection 2014.

50. Perez AG, Rodrigues AA, Luzo AC, Lana JF, Belangero WD, Santana MH. Fibrin network architectures in pure platelet-rich plasma as characterized by fiber radius and correlated with clotting time.J Mater Sci Mater Med. 2014 Aug;25(8):1967-77. doi: 10.1007/s10856-014-5235-z. Epub 2014 May 17.

51. Picoli-Quaino SK, Alves BE, Faiotto VB, Montalvao SA, De Souza CA, Annichino-Bizzacchi JM, De Paula EV. Impairment of thrombin generation in the early phases of the host response of sepsis. J Crit Care. Feb;29(1):31-36, 2014. pii: S0883-9441(13)00303-1. doi: 10.1016/j.jcrc.2013.08.015.

52. Proença-Ferreira R, Brugnerotto AF, Garrido VT, Dominical VM, Vital DM, Ribeiro Mde F, Dos Santos ME, Traina F, Olalla-Saad ST, Costa FF, Conran N. Endothelial activation by platelets from sickle cell anemia patients.PLoS One. Feb 13;9(2):e89012, 2014. doi: 10.1371/journal.pone.0089012. eCollection 2014.

53. Riccetto AG, Buzolin M, Fernandes JF, Traina F, Barjas-de-Castro ML, Silva MT, Oliveira JB,Vilela MM. Compound Heterozygous RAG2 Mutations Mimicking Hyper IgM Syndrome. J Clin Immunol 34:37, 2014

54. Riccetto AG, Buzolin M, Fernandes JF, Traina F, Barjas-de-Castro ML, Silva MT, Oliveira JB, Vilela MM. Compound Heterozygous RAG2 Mutations Mimicking Hyper IgM Syndrome. J Clin Immunol. 2013 Oct 31. [Epub ahead of print] abstract available.

55. Roversi F, Lopes MR, Machado-Neto JA, Longhini AL, Duarte AS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos PM, Favaro P, Traina F, Saad ST. SPINT2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion. Stem Cells Dev. 2014 Jan 11. [Epub ahead of print]

56. Silveira RA, Fachel AA, Moreira YB, De Souza CA, Costa FF, Verjovski-Almeida S, Pagnano KB. Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib. Hematology. Jan;19(1):31-41, 2014. doi: 10.1179/1607845413Y.0000000094.

57. Simoneti GS, Olalla Saad ST, Gilli SCO. An efficient protocol for the generation of monocyte derived dendritic cells using serum-free media for clinical applications in post remission AML patients. Annals of Clinical & Laboratory Science. 44(2):180-188, 2014.

58. Sippert E, Fujita CR, Machado D, Guelsin G, Gaspardi AC, Pellegrino Jr J, Gilli S, Saad S, Castilho L.Variant RH alleles and Rh immunisation in patients with sickle cell disease.Blood Transfus. 2014 Jun 19:1-6. doi: 10.2450/2014.0324-13. [Epub ahead of print]

59. Soares AC, Samico IC, Araújo AS, Bezerra MA, Hatzlhofer BL. Follow-up of children with hemoglobinopathies diagnosed by the Brazilian Neonatal Screening Program in the State of Pernambuco.Rev Bras Hematol Hemoter. Jul-Aug;36(4):250-255, 2014.

60. Stefanello B, De Paula EV, Orsi F, Comenalli Marques JF Jr, Roveri E G, Colella MP, Ozelo MC, Annichino-Bizzacchi JM, Addas-Carvalho M. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: A single center retrospective evaluation. J Clin Apher. 2014 Jun 3. doi: 10.1002/jca.21336. [Epub ahead of print]

61. Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, de Haas M, Hyland C, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).Vox Sang. 2013 Dec 27. doi: 10.1111/vox.12127. [Epub ahead of print]

62. Tavares CA, Borella VM, Bonon SHA, De Souza CA, Vigorito AC, Costa SCB. Detection of Cytomegalovirus and Polyomavirus in hemorrhagic cystitis after allogeneic bone marrow transplantation. BMC Infectious Diseases, in press.

63. Traina F, Campos PM, Machado-Neto JA, Duarte A S, Scopim-Ribeiro R, Barra FC, Vassalo J, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research. Aceito.

64. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia. Jan;28(1):78-87, 2014. doi: 10.1038/leu.2013.269

65. Urago KP, Morais JC, Marcos HP, Garnica M, Vassalo J, De Souza CA, Bernardo VG, Maiolino A, Milito C. Angiogenesis in multiple myeloma: comparison between two vascular markers. Pathology International, in press.

66. Zappioni KCS, Mazetto BM, Bittar LF, Barnabé A, Satinago-Bassora FD, De Paula EV, Orsi FZ, Franco-Penteado CF, Conran N, Annichino-Bizzachi JA. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels. Thrombosis Research, 2014. doi: 10.1016/j.thromres.2014.01.035. [Epub ahead of print].

67. Pazzini C, Marcato PD, Prado LB, Alessio AM, Höerh NF, Montalvão S, Paixão D, Duran N, Annichino-Bizzacchi JM. POlymeric nanoparticles of enoxaparin as a delivery system: in vivo evaluation in normal rats and in a venous thrombosis rat model. Journal of Nanoscience and Nanotechnology, 14: , 2014. [epub ahead of print].

68. Huber SC, Marcato PD, Duran N, Costa AMA, Annichinno-Bizzacchi JM. Preparation and application of mucoadhesive nanoparticles containing enoxaparin in a wound healing animal model. Current Nanoscience, 2014. aceito

 

2013

1 . Acedo SC, Gambero S, Cunha FG, Lorand-Metze I, Gambero A. Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk. In Vitro Cell Dev Biol Anim. Jun; 49(6):473-478, 2013. doi: 10.1007/s11626-013-9629-x.

2. Alessio AM, Beltrame MP, Flores Nascimento MC, Vicente CP, Godoy JAP, Santos Silva JCR, Bittar LF, Lorand-Metze I, De Paula EV, Annichino-Bizzacchi JM. Circulating Progenitor and Mature Endothelial Cells in Deep Vein Thrombosis. International Journal of Medical Sciences 10(12): 1746-1754, 2013.

3. Almeida MH, Pagnano KB, Vigorito AC, Lorand-Metze I, de Souza CA. Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center Cohort. Acta Haematol. 130(1):16-22, 2013.

4. Andrade WA, Souza Mdo C, Ramos-Martinez E, Nagpal K, Dutra MS, Melo MB, Bartholomeu DC, Ghosh S, Golenbock DT, Gazzinelli RT. Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice.Cell Host Microbe. 13(1):42-53, 2013. doi: 10.1016/j.chom.2012.12.003. Epub 2013 Jan 3.

5. Arnoni CP, Muniz JG, de Paula TA, Person RD, Gazito D, Baleotti W Jr, Barreto JA, Castilho L, Latini FR. An easy and efficient strategy for KEL genotyping in a multiethnic population.Rev Bras Hematol Hemoter.;35(2):99-1022013. doi: 10.5581/1516-8484.20130029.

6. Assis RA Seguro C, Salles F, Costa FF, Silveira PAA, Wood J, Hamerschlak N. Sobrecarga de ferro em adolescente com xerocitose: a importância da ressonância nuclear magnética. Einstein (São Paulo). 11:528 - 532, 2013.

7. AzevedoMT, Saad ST, Gilli SC. IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs.Immunol Invest. 42(8):711-725, 2013.

8 . Barbosa CG, Aleluia AC, Pacheco AP, Paz SS, Zanette AM, Lyra IM, Steinberg MH, Milton JN, Goncalves MS. Genetic modulation of HbF in Brazilians with HbSC disease and sickle cell anemia.Am J Hematol. Oct;88(10):923-924, 2013. doi: 10.1002/ajh.23538. Epub 2013 Sep 3. No abstract available.

9. Barcellos KSA, Bigarella CL, Wagner MV, Vieira KP, Lazarini M, Langford PR, Machado-Neto JA, Call SG, Staley D, Chung JY, Hansen MD, Olalla Saad ST. ARHGAP21: a new partner of alpha-tubulin involved in cell-cell adhesion formationa and essential for Epithelial-Mesenchymal Transition. J Biol Chem, 288(4):2179-2189, 2013.

10. Benites BD, Lima CS, Lorand-Metze I, Delamain MT, Oliveira GB, Almeida DD, De Souza CA, Vassallo J, Pagnano KB. Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome.Clinics (Sao Paulo) 68(3):339-343, 2013.

11. Bernardi DM, Ribeiro AF, Mazzola TN, Vilela MM, Sgarbieri VC. The impact of cystic fibrosis on the immunologic profile of pediatric patients.J Pediatr (Rio J). Jan-Feb;89(1):40-472013. doi: 10.1016/j.jped.2013.02.007.

12 . Bittar LF, de Paula EV, Montalvão SAL, Mello TBT, Annichino-Bizzacchi JM. Severe post-thrombotic syndrome is associated to higher factor VIII levels. Clinical and Applied Thrombosis/Haemostasis, 19: 570 – 573, 2013.

13. Braghini CA, Soardi FC, Vasconcellos JPC, Costa VP, Mello MP, Melo MB. New mutation in the myocilin gene segregates with juvenile open angle glaucoma in a Brazilian family. Gene;523(1):50-57. 2013.

14. Brito ABC, Delamain MT, Aguiar LL, Oliveira C, Oliveira CBM, De Souza CA, Lourenço GJ, Vassallo J, Lima CS. "Associação do polimorfismo genético VEGFR2 604T/C com agressividade no mieloma múltiplo". Applied Cancer Research, 33(1): 29, 2013.

15. Bub CB, Martinelli BM, Avelino TM, Gonçalvez AC, Barjas-Casto ML, Castro V. Platelet Antibody detection by flow citometry: an effective method to evaluate and give transfusional suport in patelet refractoriness. Rev Bras Hematol e Hemot (ABHH) 35(4):252-255, 2013.

16. Cairo JP, Oliveira LC, Uchima CA, Alvarez TM, Citadini AP, Cota J, Leonardo FC, Costa-Leonardo AM, Carazzolle MF, Costa FF, Pereira GA, Squina FM. Deciphering the synergism of endogenous glycoside hydrolase families 1 and 9 from Coptotermes gestroi. Insect Biochem Mol Biol. Oct;43(10):970-981, 2013. doi: 10.1016/j.ibmb.2013.07.007.

17. Carella AM, De Souza CA, Luminari S, Marcheselli L, Chiappella A, di Rocco A, Cesaretti M, Rossi A, Rigacci L, Gaidano G, Merli F, Spina M, Stelitano C, Hohaus S, Barbui A, Puccini B, Miranda EC, Guida A, Federico M. Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study. Leuk Lymphoma. 54(1):53-57, 2013.

18. Carneiro NK, Oda JM, Losi Guembarovski R, Ramos G, Oliveira BV, Cavalli IJ, de S F Ribeiro EM, Gonçalves MS, Watanabe MA. Possible association between TGF-β1 polymorphism and oral cancer.Int J Immunogenet. Aug;40(4):292-298, 2013. doi: 10.1111/iji.12037.

19. Carvalho JL, Braga VB, Melo MB, Campos AC, Oliveira MS, Gomes DA, Ferreira AJ, Santos RA, Goes AM. Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.J Cell Mol Med. May;17(5):617-625,2013. doi: 10.1111/jcmm.12036.

20. Castelhano MV, Reis-Alves SC, Vigorito AC, Rocha FF, Pereira-Cunha FG, De Souza CA, Lorand-Metze I. Quantifying loss of CD34(+) cells collected by apheresis after processing for freezing and post-thaw. Transfus Apher Sci. 48(2):241-246, 2013.

21. Castilho L, Reid ME. A review of the JR blood group system.Immunohematology.;29(2):63-68, 2013. Review.

22. Cohen AT, Spiro TE, Buller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong, Spyropoulos AC, Tapson V, MAGELLAN Investigators (Annichino-Bizzacchi JM). Rivaroxaban for Thromboprophylaxix in Acutely Ill Medical Patients. The New England Journal of Medicine 368:513-522, 2013.

23. Da Costa DC, Pellegrino J Jr, Guelsin GA, Ribeiro KA, Gilli SC, Castilho L. Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients.Rev Bras Hematol Hemoter. 35(1):35-38, 2013.

24. Da Luz J, Lopez P, Kimura EM, Albuquerque DM, Costa FF, Sans M, Sonati MF. A new β0-thalassemia frameshift mutation [β48 (-T)] in a Uruguayan family. International Journal of Laboratory Hematology, 35(1):111-114, 2013.

25. Da Luz J, Lopez P, Costa FF, Sans M, Sonati MF. Hb Southhampton [B106(G8)Leu-PRO,CTG-CCG] in an Uruguayan woman. Revista Brasileira de Hematologia, 35(2):146-147, 2013. Doi 10.5581/1516-8484.20130037.

26. Da Luz JD, Avila A, Icasuriaga S, Gongóra M, Castillo L, Serrón A, Kimura EM, Costa FF, Sans M, Sonati Mde F. Frequency and spectrum of hemoglobinopathy mutations in a Uruguayan pediatric population. Genet Mol Biol. Sep;36(3):316-322, 2013. doi: 10.1590/S1415-47572013005000027.

27. De Almeida MH, Pagnano KBB, Vigorito AC, Lorand-Metze I, De Souza CA. Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center Cohort. Acta Haematol., 130:16–22, 2013.

28. De Cássia Carvalho Melo R, Arouca MM, Bigarella CL, Baratti MO, de Melo Campos P, Traina F, Saad ST. Low expression of TIMP-2 may be associated with high-risk myelodysplastic syndrome. Leuk Lymphoma. 54(5):1091-1093, 2013.

29. De Mara CS, Duarte AS, Sartori-Cintra AR, Luzo AC, Saad ST, Coimbra IB. Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6.Rheumatol Int. Jan;33(1):121-128, 2013.

30. de Oliveira Filho RA, Silva GJ, de Farias Domingos I, Hatzlhofer BL, da Silva Araújo A, de Lima Filho JL, Bezerra MA, Martins DB, de Araújo RF.Association between the genetic polymorphisms of glutathione S-transferase (GSTM1 and GSTT1) and the clinical manifestations in sickle cell anemia.Blood Cells Mol Dis. Aug;51(2):76-79, 2013. doi: 10.1016/j.bcmd.2013.03.003. Epub 2013 Apr 13.

31. De Souza CA, Covas DT, Langhi Jr DM, Maiolino A, Moraes-Souza H, Rego EM, Falcão RP, Bordin JO, Rugani M, Magalhães SMM, Marques Junior JF, Fabron Jr. A, Chiattone CS, Amorim Filho AG. There is no scientific evidence to support the practice of collecting and storing umbilical cord blood in private blood banks". Rev Bras Hematol Hemoter., 35(2): 75-76, 2013.

32. De Souza CA, Pagnano KBB, Bendit l, Conchon M, Freitas CMMM, Coelho AM, Funke VAM, Bernardo WM. Leucemia mieloide crônica. Rev. Assoc. Med. Bras., 59(3): 220-232, 2013.

33. Deus-Silva L, Bonilha L, Pereira Damasceno B, Costa AL, Lin Yasuda C, Costa FF, Santos AO, Etchebehere E, Oquendo-Nogueira R, Fockink R, Fróes de Freitas C, Camargo EE, Li Min L, Cendes F, Ollala Saad S. Brain perfusion impairment in neurologically asymptomatic adult patients with Sickle-Cell Disease shown by voxel-based analysis of SPECT images.  Frontiers in Neurodegeneration. 4:207, 2013.

34. Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM, Miranda EC, Aranha FJ, Oliveira-Duarte G, Fernandes VC, De Souza CA, Costa SC, Vigorito AC. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect Dis. 13:310, 2013.

35. Falorio S, Biasoli I, Luminari S, Quintana G, Musso M, Dell'olio M, Specchia MR, di Renzo N, Cesaretti M, Buda G, Vallisa D, Mannina D, Andriani A, Chiattone CS, Delamain MT, de Souza CA, Spector N, Angrilli F, Federico M. Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.Hematol Oncol. 2012 Oct 2. doi: 10.1002/hon.2029. [Epub ahead of print]

36. Favaro P, Traina F, Machado-Neto JA, Lazarini M, Lopes MR, Pereira JK, Costa FF, Infante E, Ridley AJ, Saad ST. FMNL1 promotes proliferation and migration of leukemia cells.J Leukoc Biol. 94(3):503-512, 2013. doi: 10.1189/jlb.0113057.

37. Fernandes HP, Fontes A, Thomaz A, Castro V, Cesar CL, Barjas-Castro ML. Measuring red blood cell aggregation forces using double optical tweezers. Scand J Clin Lab Invest. 73(3):262-264, 2013.

38. Fernandes JL, Sampaio EF, Fertrin K, Coelho OR, Loggetto S, Piga A, Verissimo M, Saad ST. Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.Am J Med. 126 (9):834-837, 2013. doi: 10.1016/j.amjmed.2013.05.002.

39. Ferreira AA, Ferreira MG, Ramos MMS, Borges LV, Santana JMA, Pereira GA, Silva MV, Botelho filho A, Borges CM, Garcia FB, Silva KFN, Castro V, Silva SS, Moraes-Souza H. Segurança transfusional:avaliação .da produção, distribuição e eficácia transfusional do concentrado de plaquetas na hemorrede do estado de Minas Gerais. Gerais: Revista de Saúde Pública do SUS/MG, 1:143-144, 2013.

40. Fiusa MML, Costa-Lima C, Souza GR, Vigorito AC, Aranha FJP, Lorand-Metze I, Annichino-Bizzacchi JM, De Paula EV. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia. Critical Care, 17(4):R169, 2013.

41. Fonseca SF, Moura Neto JP, Goncalves MS. Prevalence and molecular characterization of β-thalassemia in the state of Bahia, Brazil: first identification of mutation HBB: c.135delC in Brazil.Hemoglobin.;37(3):285-290,2013. doi: 10.3109/03630269.2013.771271.

42. Fröhlich Archangelo L, Greif PA, Maucuer A, Manceau V, Koneru N, Bigarella CL, Niemann F, Santos MT, Kobarg J, Bohlander SK, Olalla Saad ST. The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS). Biochimica et Biophysica Acta - Molecular Cell Research, 1833(5):1269-1279, 2013.

43. Gil GP, Ananina G, Oliveira MB, Costa FF, Silva MJ, Santos MN, Bezerra MA, Hatzlhofer BL, Araujo AS, Melo MB. Polymorphism in the HMOX1 gene is associated with high levels of fetal hemoglobin in Brazilian patients with sickle cell anemia. Hemoglobin.;37(4):315-324,2013. doi: 10.3109/03630269.2013.789438.

44. Grumach AS, Valle SO, Toledo E, de Moraes Vasconcelos D, Villela MM, Mansour E, Pinto JA, Campos RA, França AT; group interested on HAE (GINHA). Hereditary angioedema: first report of the Brazilian registry and challenges. J Eur Acad Dermatol Venereol 27(3):e338-344, 2013.

45. Gupta V, Richards S, Rowe J; Acute Leukemia Stem Cell Transplantation Trialists' Collaborative Group. Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.Blood. 2013 Jan 10;121(2):339-350. doi: 10.1182/blood-2012-07-445098.

46. Latini FR, Bastos AU, Arnoni CP, Muniz JG, Person RM, Baleotti W Jr, Barreto JA, Castilho L, Cerutti JM. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol Dis. 50(3):161-165, 2013.

47 . Latini FR, Gazito D, Arnoni CP, Muniz JG, De Medeiros Person R, Carvalho FO, Baleotti Jr W, Castilho L, Barreto JA. A new strategy to identify rare blood donors: single polymerase chain reaction multiplex SNaPshot reaction for detection of 16 blood group alleles.Blood Transfus. 17:1-8, 2013. doi: 10.2450/2013.0242-12.

48. Lazarini M, Machado-Neto JÁ, Frohlich Archangelo L, Mendes-Silva BF, Bigarella CL, Traina F, Olalla Saad ST. PTK2 and PTPN11 expression in myelodysplastic syndromes. Clinics 68(10):1371-1375, 2013.

49. Lazarini M, Traina F, Machado-Neto JA, Barcellos KS, Moreira YB, Brandão MM, Verjovski-Almeida S, Ridley AJ, Saad ST.  ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells. Biochim Biophys Acta. Feb;1832(2):365-374, 2013.

50. Lopes, MR, Traina F, Melo Campos, P, Pereira JKN, Machado-Neto JA, Machado HC, Gilli SCO, Olalla Saad ST, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research 37 (5):541-546, 2013.

51. Lorga Filho A M; Azmus AD; Soeiro AM; Quadros AS; Avezum Junior A; Marques AC; Franci A; Manica ALL; Volschan A; De Paola AAV; Greco AIL; Ferreira ACN; Sousa ACS; Pesaro AEP; Simão AF; Lopes ASSA; Timerman A; Ramos AIO; Alves BR; Caramelli B; Mendes BA; Polanczyk CA; Montenegro CEL; Barbosa CJDG; Serrano Junior CV; Melo CCL; Pinho C; Moreira DAR; Calderaro D; Gualandro DM; Armaganijan D; Machado Neto EA; Bocchi EA; Paiva EF; Stefanini E; D'Amico E; Evaristo EF; Silva EER; Fernandes F; Brito Junior FS; Bacal F; Ganem F; Gomes FLT; Mattos FR; Moraes Neto FR; Tarasoutchi F; Darrieux FCC; Feitosa GS; Fenelon G; Morais GR; Correa Filho H; Castro I; Gonçalves Junior I; Atié J; Souza Neto JD; Ferreira JFM; Nicolau JC; Faria Neto JR; Annichino-Bizzacchi JM; Zimerman LI; Piegas LS; Pires LJT; Baracioli LM; Silva LB; Mattos LAP; Lisboa LAF; Magalhães LPM; Lopes MACQ; Montera MW; Figueiredo MJO; Malachias MVB; Gaz MVB; Andrade MD; Bacellar MSC; Barbosa MR; Clausell NO; Dutra OP; Coelho OR; Yu PC; Lavítola PL; Lemos Neto PA; Andrade PB; Farsky PS; Franco RA; Kalil RAK; Lopes RD; Esporcatte R; Heinisch RH; Kalil Filho R; Giraldez RRCV; Alves RC; Leite REGS; Gagliardi RJ; Ramos RF; Montenegro ST; Accorsi TAD; Jardim TSV; Scudeler TL; Moisés VA; Portal VL. Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia. Arq. Bras. Cardiol. vol.101 no.3 supl.3 São Paulo Sept. 2013.

52. Luzo AC. Human T lymphotropic virus types 1 and 2: a point of view. Rev Bras Hematol Hemoter.;35(4):240-241, 2013. doi: 10.5581/1516-8484.20130096.

53. McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of basic oral care for the management of oral mucositis in cancer patients.Support Care Cancer. Nov;21(11):3165-3177, 2013. doi: 10.1007/s00520-013-1942-0.

54. Mendonça-Louzeiro MR, Annichino-Bizzacchi JM, Magna LA, Quaino SK, Benetti-Pinto CL. Faster thrombin generation in women with polycystic ovary syndrome compared with healthy controls matched for age and body mass index. Fertility and Sterility 99(6):1786-1790, 2013.

55. Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, Cappellano P, Fertrin KY, Carlesse F, Simões B, Bergamasco MD, Cunha CA, Seber A, Ribeiro MP, Queiroz-Telles F, Lee ML, Chauffaille ML, Silla L, de Souza CA, Colombo AL. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.Clin Microbiol Infect. 2012 Sep 25. doi: 10.1111/1469-0691.12002.

56. Oliveira MS, Melo MB, Carvalho JL, Melo IM, Lavor MS, Gomes DA, de Goes AM, Melo MM. Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.J Cancer Sci Ther.;5(2):52-57, 2013.

57. Orsi FA, Angerami RN, Mazetto BM, Quaino SNKP, Santiago-Bassora F, Castro V, de Paula EV, Annichino-Bizzacchi JM. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case--control study comparing dengue fever patients with and without bleeding manifestations. BMC Infectious Diseases (Online). 13:350-360, 2013.

58 . Palodetto B, Campos PM, Benites BD, Chauffaille MLLF, Velloso EDRP, Traina F, Olalla Saad ST. MDR-1 and GST polymorphisms are involved in Myelodysplasia progression. Leukemia Research, 37 (8): 970-973, 2013.

59. Pereira JA, López P, Costa FF, Sans M, Sonati Mde F Hb Southampton [B106(G8)Leu→PRO, CTG→CCG] in a Uruguayan woman. Rev Bras Hematol Hemoter. 35(2):146-147, 2013;. doi: 10.5581/1516-8484.20130037.

60. Pereira-Cunha FG, Duarte AS, Costa FF, Saad ST, Lorand-Metze I, Luzo AC. Viability of umbilical cord blood mononuclear cell subsets until 96 hours after collection.Transfusion. 53(9):2034-2042, 2013 Sept. doi: 10.1111/trf.12078

61. Perez AG, Lichy R, Lana JF, Rodrigues AA, Luzo AC, Belangero WD, Santana MH. Prediction and modulation of platelet recovery by discontinuous centrifugation of whole blood for the preparation of pure platelet-rich plasma. Biores Open Access. Aug;2(4):307-314, 2013. doi: 10.1089/biores.2013.0015.

62. Pinto M, Barjas-Castro ML, Nascimento S, Falconi MA, Zulli R, Castro V. The new noninvasive occlusion spectroscopy hemoglobin measurement method: a reliable and easy anemia screening test for blood donors.Transfusion. 53(4):766-769, 2013.

63. Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF; B-LONG Investigators. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.N Engl J Med. Dec 12;369(24):2313-2323, 2013. doi: 10.1056/NEJMoa1305074. Epub 2013 Dec 4.

64. Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MD, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille MD, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood 121(11):1935-43, 2013.

65.  Reis-Alves SC, Traina F, Harada G, Campos PM, Saad ST, Metze K, Lorand-Metze I. Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores. PLoS One. 2013 Dec 6;8(12):e81048. doi: 10.1371/journal.pone.0081048.

66. Roversi FM, da Cunha AF, Brugnerotto AF, Carazzolle MF, de Albuquerque DM, Lanaro C, Machado-Neto JA, Olalla Saad ST, da Costa FF. Gene Expression Analysis of the Brazilian Type of Hereditary Persistence of Fetal Hemoglobin: Identification of Genes that Could be Related to γ-Globin Activation. Hemoglobin. 37(6):516-535, 2013.]

67. Sakamoto TM, Canalli AA, Traina F, Franco-Penteado CF, Gambero S, Saad ST, Conran N, Costa FF. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.Clin Biochem. 46(18):1798-1803, 2013.

68. Sakamoto TM, Lanaro C, Ozelo MC, Garrido VT, Olalla-Saad ST, Conran N, Costa FF. Increased adhesive and inflammatory properties in blood outgrowth endothelial cells from sickle cell anemia patients. Microvasc Res. 90:173-179, 2013.

69.  Santos MD, Duarte AS, Carvalho GM, Guimarães AC, Zappelini CE, Coelho Dal Rio AC, Corrêa ME, Milani Altemani AM, Danielli Nicola EM. Linear epidermal nevus of the oral cavity: a rare diagnosis. Case Report Med. 2012;2012:206836. doi: 10.1155/2012/206836. Epub 2012 Jun 28.

70. Silveira AA, Dominical VM, Lazarini M, Costa FF, Conran N. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity. Inflamm Res. 62(2):127-132, 2013.

71. Soares TC, Correa ME, Cintra GF, Miranda EC, Cintra ML. The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients.Bone Marrow Transplant. Nov;48(12):1525-1529, 2013. doi: 10.1038/bmt.2013.105.

72. Sonati MF. α-chain hemoglobin variants with electrophoretic mobility similar to that of hemoglobin S in newborn screening programs. Revista Brasileira de Hematologia e Hemoterapia (Impresso), 35: 85-86, 2013.

73. Toukh M, Ozelo MC, Angelillo-Scherrer A, Othman M. A novel use of thromboelastography in type 2B von Willebrand disease. Int J Lab Hematol. Dec;35(6):e11-14, 2013. doi: 10.1111/ijlh.12095.

74. Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype.Haematologica. Sep;98(9):e105-107,2013.

75.  White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E. Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale. Clin Chem. Jun;59(6):938-948, 2013. doi: 10.1373/clinchem.2012.196477.

 

2012

1. Almeida CB, Scheiermann C, Jang JE, Prophete C, Costa FF, Conran N, Frenette PS. Hydroxyurea anda a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. Blood, 120: 2879-2888, 2012.

2. Andreoli-Risso MF, Duarte ASS, Ribeiro TB, Bordeaux-Rego P, Luzo A,. Baratti M O, Adur J, de Thomaz AA, Pelegati VB, Carvalho HF, Cesar C L, Kharmadayan P, Costa FF, Olalla-Saad ST, "Second-harmonic generation microscopy used to evaluate the effect of the dimethyl sulfoxide in the cryopreservation process in collagen fibers of differentiated chondrocytes", Proc. SPIE 8226, 82263G (2012); http://dx.doi.org/10.1117/12.909284 (publicação  completa de congresso).

3. Bellei M; Chiattone CS, Luminari S, Pesce EA, Cabrera ME, De Souza CA, Gabús R, Zoppegno L, Milone J, Pavlovsky A, Connors JM, Foss FM, Horwitz SM, Liang R, Montoto, S, Pileri AS, Polliack A, Vose JM, Zinzani PL, Zucca E, Federico M. T-Cell Lymphomas in South America and Europe. Revista Brasileira de Hematologia e Hemoterapia 34: 42-47, 2012.

4. Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network (Castro M). The international factor IX treatment network survey. Haemophilia. 18(3):e60-62, 2012.

5. Bigarella CL, Vieira Ferro KP, Barcellos KS, Martins-de-Souza D, Traina F, Novello JC, Olalla Saad ST, Archangelo LF. Post-translational modification of the RhoGTPase activating protein 21, ARHGAP21, by SUMO2/3. FEBS Lett. 586: 3522–3528, 2012.

6. Bittar LF, de Paula EV, Montalvão SAL, Mello TBT, Annichino-Bizzacchi JM. Severe post-thrombotic syndrome is associated to higher factor VIII levels. Clinical and Applied Thrombosis/Haemostasis, 2012 [epub ahead of print].

7. Bittencourt RI ; Vassallo J, Chauffaile ML, Xavier SG, Pagnano, K, Nascimento ACK, De Souza CA, Chiattone C . Philadelphia-negative chronic myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia 34: 140-149, 2012.

8. Bom EA, de Souza CV, Thiesen RA, Miranda EC, de Souza CA . Evaluation of respiratory conditions in early phase of hematopoietic stem cell transplantation.Rev Bras Hematol Hemoter. 34(3):188-192, 2012.

9. Bordeaux-Rego P, Baratti M O, Duarte ASS, Ribeiro TB, Andreoli-Risso MF, Vidal B. Miranda JB, Adur J, de Thomaz AA, Pelegati VB, Costa FF, Carvalho HF, Cesar CL, Luzo A. Olalla Saad ST. Use of the second harmonic generation microscopy to evaluate chondrogenic differentiation of mesenchymal stem cells for cartilage repair", Proc. SPIE 8226, 82263N (2012); http://dx.doi.org/10.1117/12.909185 (publicação  completa de congresso)

10. Cardozo DM, Lieber SR, Marques SB, Aranha FJ, Vigorito AC, de Souza CA, Visentainer JE. Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation..Sao Paulo Med J.130(4):219-224, 2012.

11. Castilho L. Applying molecular immunohematology discoveries to daily transfusion practice. Rev Bras Hematol Hemoter. 34(3):184-185, 2012.

12. Colella MP, de Paula EV, Conran N, Machado-Neto JA, Annichino-Bizzacchi JM, Costa FF, Saad ST, Traina F. Hydroxyurea is associated with reduction of hypercoagulability markers in sickle cell anemia. J Thromb Haemost, 10:1967-1970, 2012.

13. Colella MP, Duarte GC, Marques Jr JFC, De Paula EV. Hemostatic management of extreme challenges to hemostasis in acquired von Willebrand Syndrome. Haemophilia, early online edition – 18(3):e188-191, 2012 .

14. Colella MP, Fiusa MM, Orsi FL, De Paula EV, Annichino-Bizzacchi JM. Performance of a point of care device in determining prothrombin time in an anticoagulation clinic. Blood Coagulation and Fibrinolysis, 23(2):172-174, 2012.

15. Costa-Lima C, Fiusa MM, Annichino-Bizzacchi JM, De Paula EV. Prothrombin complex concentrates in warfarin anticoagulation reversal.Rev Bras Hematol Hemoter. 34(4):302-304, 2012.

16. Cunha FG, da Rocha FF, Lorand-Metze IG.The utility of multiparametric flow cytometry for the detection of minimal residual disease in acute lymphoblastic leukemia.Rev Bras Hematol Hemoter. 34(5):396, 2012.

17. D Hatzlhofer BL, Bezerra MA, Santos MN, Albuquerque DM, Freitas EM, Costa FF, Araújo AS, Muniz MT. MTHFR Polymorphic Variant C677T Is Associated to Vascular Complications in Sickle-Cell Disease. Genet Test Mol Biomarkers. 16:1038-1043, 2012.

18. Da Luz J, López P, Kimura EM, Albuquerque DM, Costa FF, Sans M, Sonati MF. A new β(0) -thalassemia frameshift mutation [β48 (-T)] in a Uruguayan family.Int J Lab Hematol. 35(1):111-114, 2012.

19. De Almeida AC, Barbosa SM, Lourdes Rios Barjas-Castro M, Olalla Saad ST, Condino-Neto A. IFN-beta, IFN-gamma and TNF-alpha decrease erythrophagocytosis by human monocytes independent of SIRP-alpha or SHP-1 expression. Immunpharmacol Immunotoxicol, 34(6):1054-1059, 2012.

20 . De Castro V. Proficiency testing: impact on safety and quality of blood bank services and networks. Rev Bras Hematol Hemoter. 34(2):73-74, 2012.

21. De Mello MR, Albuquerque DM, Pereira –Cunha FG, Albanez KB, Pagnano KB, Costa FF, Metze K, Lorand-Metze I. Molecular characteristics and chromatin texture features in acute promyelocytic leukemia. Diagn Pathol 7:75, 2012.

22. De Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, Nemes L, Salek S, Shima M, Windyga W, Ehrenforth S, Chuansumrit A, for the 1804 (AdeptTM1) investigators. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for the treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. Journal of Thrombosis and Haemostasis, 10:81-89, 2012.

23. De Paula EV. Comments on: Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions.Rev Bras Hematol Hemoter.34(3):180-181, 2012.

24. De Souza CA, Pagnano KB, Bendit I, Conchon M, Freitas CM, Coelho AM, Funke VA, Bernardo WM. Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012. Rev Bras Hematol Hemoter. 34(5):367-382, 2012.

25.  De Souza CV, Miranda EC, Garcia C Jr, Aranha FJ, de Souza CA, Vigorito AC. Functional evaluation indicates physical losses after hematopoietic stem cell transplantation.Rev Bras Hematol Hemoter. 34(5):345-351, 2012.

26. De Souza, CA. What is happening with the supply of oncology drugs in Brazil and the world? Revista Brasileira de Hematologia e Hemoterapia 34:1-2, 2012.

27. Dhyani A, Duarte ASS, Machado-Neto JA, Favaro P, Ortega MM, Olalla Saad ST. ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. FEBS, 586(24):4311-4318.2012.

28. Dos Santos JL, Lanaro C, Chelucci RC, Gambero S, Bosquesi PL, Reis JS, Lima LM, Cerecetto H, González M, Costa FF, Chung M. Design, Synthesis and Pharmacological Evaluation of Novel Hybrid Compounds to Treat Sickle Cell Disease Symptoms. Part II Furoxan derivatives. J Med Chem. 55(17):7583-7592,2012.

29. Faber EW, Lourenço GJ, Ortega MM, Lorand-Metze I, De Souza CA, Lima CS P. Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk. Hematological Oncology 30: 105-107, 2012.

30. Fattori A, Fertrin KY, Albuquerque DM, Bezerra MA, Santos MN, Castro SM, Costa FF. Thalassemia major phenotypes secondary to the association of beta 5ÚTR +20 (C to T) allele with beta 39 (C to T). Eur J Haematol, 89(3):273-275,2012.

31. Fernandes JL, Silveira MA, Fertrin K, Lauar S, Fattori A, Coelho O, Junqueira FP, da Cunha GM, Coutinho AC Jr, Pereira FB, Verissimo M, Saad ST. Left and right ventricular function and volume assessment in young thalassemia major patients with no related myocardial iron overload. Ann Hematol. 91(12):1839-1844, 2012.

32. Flores-Nascimento MC, Orsi FL, Yokoyama AP, Pereira FG, Lorand-Metze I, De Paula EV, Castro V, Annichino-Bizzacchi JM. Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause. Blood Coagul Fibrinolysis. 23(1):75-77, 2012.

33. Flores-Nascimento MC, Paes-Leme AF, Mazetto BM, Zanella JL, de Paula EV, Annichino-Bizzacchi JM. Inflammatory, Immune and Lipid Transportation Proteins are Differentially Expressed in Spontaneous and Proximal Deep Vein Thrombosis Patients. Thrombosis Research, 130(5):e246-50. 2012.

34. Garrido VT, Proença-Ferreira R, Dominical VM, Traina F, Bezerra MA, de Mello MR, Colella MP, Araujo AS, Saad ST, Costa FF, Conran N. Elevated plasma levels and platelet associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT) in sickle cell disease. Br J Haematol, 158(6):788-797, 2012.

35 . Gilli SCO, Medina SS, Castro V, Fernandes LGR, Olalla Saad ST. Platelet associated Ig G may be related with thrombocytopenia in patients with myelodysplastic syndromes. Leukemia Research, 36:554-559, 2012.

36. Hare SS, Souza CA, Bain G, Seely JM, Frcpc, Gomes MM, Quigley M . The radiological spectrum of pulmonary lymphoproliferative disease.Br J Radiol. 85(1015):848-864, 2012. Review.

37. Hatzlhofer D BL, Bezerra MA, Santos MN, Albuquerque DM, Freitas EM, Costa FF, Araújo AS, Muniz MT. MTHFR Polymorphic Variant C677T Is Associated to Vascular Complications in Sickle-Cell Disease.Genet Test Mol Biomarkers. 16(9):1038-1043.2012.

38. Horn T, Castilho L, Moulds JM, Billingsley K, Vege S, Johnson N, Westhoff CM. A novel JKA allele, nt561C>A, associated with silencing of Kidd expression. Transfusion. 52(5):1092-1096, 2012.

39. Jorge SEDC, Petruk AA, Kimura EM, Oliveira DM, Caire L, Suemasu CN, Oliveira PA, Albuquerque DM, Costa FF, Skaf MS, Martinez L, Sonati MF. Hb S-São Paulo: a new sickling hemoglobin with stable polymer and decreased oxygen affinity. Archives of Biochemistry and Biophysics, 519(1):23-31, 2012.

40. Lopes-Pires ME, Marcondes S, Lorand-Metze I, Casarin AL, Antunes E, Pereira-Cunha FG. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation. Platelets 23: 195-201, 2012.

41. Machado-Neto JA, Favaro P, Lazarini M, Duarte ASS, Frolich-Archangelo L, Lorand-Metze I, Costa FF, Olalla Saad ST, Traina F. Downregulation of IRS2 in myelodysplastic syndrome: A possible role in impaired hematopoietic cell differentiation. Leukemia Research, 36:931-935, 2012.

42. Machado-Neto JA, Traina F, Melo Campos P, Andreoli M, Costa FF, Olalla Saad ST. Lack of association  between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome. Neoplasma, 59(5):530-535, 2012.

43. Maiolino A, Hungria VT, Garnica M, Oliveira-Duarte G, Oliveira LC, Mercante DR, Miranda EC, Quero AA, Peres AL, Barros JC, Tanaka P, Magalhães RP, Rego EM, Lorand-Metze I, Lima CS, Renault IZ, Braggio E, Chiattone C, Nucci M, de Souza CA; Brazilian Multiple Myeloma Study Group (BMMSG/GEMOH).Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma.Am J Hematol. 87(10):948-952, 2012.

44. Mara CS, Duarte ASS, Sartori-Cintra AR, Luzo ACM, Saad STO, Coimbra IB. Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6. Rheumatol Int, 33(1):121-128 2012.

45. Mazetto BM, Orsi FL, Barnabé A, De Paula EV,, Flores-Nascimento MC, Annichino-Bizzacchi JM. Increased ADAMTS13 activity in patients with venous thromboembolism. Thrombosis Research, 130(6):889-893, 2012.

46. Mota M, Dezan M, Valgueiro MC, Sakashita AM, Kutner JM, Castilho L.  RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.. J Clin Lab Feb;26(2):104-108, 2012.

47. Nicolini FE, Turkina A, Shen Zhi-Xiang, Gallagher N, Jootar S, Powell BL, Zheng M, Szczudlo T, le Coutre P, De Souza CA. Expanding Nilotinib Access in Clinical Trials (ENACT). Cancer. 118(1):118-126, 2012.

48. Ozelo MC, Matta MAP, Yang R. Meeting the challenges of haemophilia care and patient support in China and Brazil. Haemophilia 18: 33-38, 2012.

49. Ozelo MC. Surgery in patients with hemophilia: Is thromboprophylaxis mandatory? Thrombosis Research 130: S23-S26, 2012.

50. Peffault de Latour R, Schrezenmeier H, Bacigalupo A, Blaise D, de Souza CA, Vigouroux S, Willemze R, Terriou L, Tichelli A, Mohty M, de Guibert S, Marsh JC, Passweg J, Yves Mary J, Socié G. Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria. Haematologica. 97(11):1666-1673, 2012.

51. Pereira BMT, Fraga GP, Hirano ES, Carmona CV, Ozelo MC. Non-operative management of blunt major hepatic injury in a young adult with severe haemophilia A. Haemophilia 18: e84-e86, 2012.

52. Pereira JK, Traina F, Machado-Neto JA, Duarte ASS, Lopes MR, Saad ST, Favaro P. Distinct expresasion profiles of MS12 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients. Leuk Res, 36(10):1300-1303, 2012.

53. Pio SF, Ozelo MC, Dos Santos A, de Carvalho BV, Caram C, Zouain D, Oliveira GC, Rezende SM. Factor VIII inhibitors in patients with congenital severe haemophilia A and its relation to genotype. Haemophilia. 18(6):e411-414, 2012.

54. Rego EM, Kim HT, Ruiz-Arguelles GJ, Uriarte R, Jacomo RH, Guttierrez-Aguirre H, Melo RA, Bittencourt RI, Pasquini R, Pagnano K, Fagundes EM, Chauffaile ML, Chiattone C, Martinez L, Meillon L, Gomez-Almaguer D, Kwan HC, Garces-Eiseles J,; Gallagher RE, Niemeyer CN, Lowenberg B, Lo-Coco F, SANZ M . The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL). Hematology 17: 36-38, 2012.

55. Silva DC, Jovino CN, Silva CA, Fernandes HP, Filho MM, Lucena SC, Costa AM, Cesar CL, Barjas-Castro ML, Santos BS, Fontes A. Optical Tweezers as a new biological tool to measure zeta potential of stored red blood cels. Plos One Vol 7(2):31778, 2012

56. Silva DC, Jovino CN, Silva CA, Fernandes HP, Filho MM, Lucena SC, Costa AM, Cesar CL, Barjas-Castro ML, Santos BS, Fontes A. Optical tweezers as a new biomedical tool to measure zeta potential of stored red blood cells.PLoS One. 7(2):e31778, 2012.

57. Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, Albuquerque DM, Santos MN, Fertrin KY, Costa FF, Araujo A, Bezerra MA. JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil. Genet Test Mol Biomarkers, 16(7):802-5. 2012.

58. Souto LMR, Chaim EA, Annichino-Bizzacchi JM. Increased intraoperative bleeding in patients undergoing abdominoplasties after gastroplasty is not due to coagulopathy. Aesthetic Plastic Surgery, 36(6):1283-1291, 2012.

59. Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV. Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis. PLoS One. 2012;7(8):e43090, 2012.

60. Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, Rogers HJ, Sekeres MA, Maciejewski JP, Tavares AA, Tiu RV. SF3B1, A Splicing Factor is Frequently Mutated in Refractory Anemia with Ring Sideroblasts. Leukemia 26:542-545, 2012.

61. Zaccariotto TR, Lanaro C, Albuquerque DM, Santos MN, Bezerra MA, Cunha FG, Lorand-Metze I, Araujo AS, Costa FF, Sonati MF.Expression profiles of phosphatidylinositol phosphate kinase genes during normal human in vitro erythropoiesis.Genet Mol Res. 11(4):3861-3868, 2012.

 

2011

1. Abramczuk BM, Mazzola TN, Moreno YM, Zorzeto TQ, Quintilio W, Wolf PS, Blotta MH, Morcillo AM, da Silva MT, Dos Santos Vilela MM. Impaired humoral response to vaccines among HIV-expósed uninfected infants. Clin Vaccine Immunol. Sep; 18(9):1406-1409, 2011.

2. Almeida CB, Favero ME, Pereira-Cunha FG, Lorand-Metze I, Olalla Saad ST, Costa FF, Conran N. Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease. Experimental Biology and Medicine 236:1239-1246, 2011.

3. Almeida EB, Milanez H, Lorand-Metze I. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infectious Diseases 1-34, 2011.

4. Alves BE, Montalvao SAL, Aranha FJP, Lorand-Metze I, De Souza CA, Annichino-Bizzacchi JM, De Paula EV. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study. Journal of Translational Medicine 9:23-31, 2011.

5. Amaral DR, Credidio DC, Pellegrino Jr J, Castilho L. Fetal DNA genotyping by analysis of maternal plasma in a mixed population. Journal of Clinical Laboratory Analysis 25: 100-104, 2011.

6. Baldanzi G, Traina F, Marques Neto JF, Santos AO, Ramos CD, Olalla Saad ST. Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease. Clinics 66(5):801-805, 2011.

7. Baleotti Jr W, Suzuki RB, Polotto M, Ruiz MO, Fabron Jr A, Castilho L. A PCR-based strategy for Dombrock screening in Brazilian blood donors reveals a novel allele: the DO*A-WL . J Clin Lab Anal. 25: 79–82, 2011.

8. Bittar LF, de Paula EV, Mello TB, Siqueira LH, Orsi FL, Annichino-Bizzacchi JM. Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation with Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis. ClinAppl Thromb Hemost. 17(5):514-518, 2011.

9. Bizzetto R, Bonfim C, Rocha V, Socié G, Locatelli F, Chan KW, Ramirez O, Stein J, Nabhan SK, Miranda ECM, Passweg J, De Souza CA, Gluckman E. Outcomes after related and unrelated umbilical cord blood transplantation for non-Fanconi hereditary bone barrow failure. Haematologica 96:134-142, 2011.

10. Bonon SHA, Parola DC, Thomasini RL, Roesler BM, Aranha FJP, de Souza CA, Vigorito AC, Costa SCB. “Betaherpesvirus (CMV, Hhv-6, and Hhv-7) Active infections in Brazilian Hematopoietic Stem Cell Transplantation Patients” J Bioanal Biomed 2011S4:001.

11. Borges-Almeida E, Milanez HM, Vilela MM, Cunha FG, Abramczuk BM, Reis-Alves SC, Metze K, Lorand-Metze I. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.BMC Infect Dis, 11:38, 2011.

12. Cabral CH, Serafim ES, de Medeiros WR, de Medeiros Fernandes TA, Kimura EM, Costa FF, de Fátima Sonati M, Rebecchi IM, de Medeiros TM. Determination of βhaplotypes in patients with sickle-cell anemia in the state of Rio Grande do Norte, Brazil.Genet Mol Biol 34:421-424, 2011.

13. Cajado CS, Cerquiera BAV, Couto FD,Moura Neto JP, Villas-Boas W, Dorea MJ, Lyra IM, Barbosa CG, Reis MG, Goncalves, MS. TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine 1: 1-2, 2011.

14. Canalli AA, Ferreira Proença R, Franco-Penteado CF, Traina F, Sakamoto TM, Olalla Saad ST, Conran N, Costa FF. Participation of the Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin. Haematologica, 96 (04): 526-533, 2011.

15. Castilho L, Suzuki RB, Polotto M, Ruiz MO, Fabron A. A PCR-based strategy for Dombrock screening in Brazilian blood donors reveals a novel allele: the DO*A-WL. Journal of Clinical Laboratory Analysis 25: 79-82, 2011.

16. Cerqueira BAV, Villas-Boas W, Zanete Â, Reis MG, Goncalves MS. Increased concentrations of IL-18 and uric acid in sickle cell anemia: Contribution of hemolysis, endothelial activation and the inflammasome. Cytokine  S1043-4666(11)0, 2011.

17. Credidio DC, Pellegrino Jr, J, Castilho L. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy. Immunohematology 27: 6-11, 2011.

18. da Silveira ZM, das Vitórias Barbosa M, de Medeiros Fernandes TA, Kimura EM, Costa FF, Sonati FM, Rebecchi IM, de Medeiros TM. Characterization of beta-thalassemia mutations in patients from the state of Rio Grande do Norte, Brazil.Genet Mol Biol. 34(3):425-428, 2011.

19. Dominical VM, Bértolo MB, Almeida CB, Garrido VT, Miguel LI, Costa FF, Conran N. Neutrophils of rheumatoid arhtritis patients on anti-TNF-alpha therapy and in disease remission present reduced adhesive functions, in association with decreased circulating neutrophil-atractant chemokine levels. Scandinavian Journal of Immunology, 73(4):309-318, 2011.

20. Faber EW, Lourenço GJ, Ortega MM, Lorand-Metze I, De Souza CA, Lima CSP. Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk. Hematological Oncology, 2011.

21. Fabri DR, De Paula EV, Costa DS, Annichino-Bizzacchi JM, Arruda VR. Novel insights on the development of atherosclerosis in hemophilia A mouse models. Journal of Thrombosis and Haemostasis, 9(8):1556-1561, 2011.

22. Favaro P, Finn JD, Siner JI, Wright JF, High KA, Arruda VR. Safety of Liver Gene Transfer Following Peripheral Intravascular Delivery of Adeno-Associated Virus (AAV)-5 and AAV-6 in a Large Animal Model. Human Gene Therapy 22: 110308131850056, 2011.

23. Favero ME, Costa FF. Alpha-Hemoglobin-Stabilizing protein: An erythroid molecular Chaperone. Biochemistry Research International 2011:01-07, 2011.

24. Fernandes HP, Cesar CL, Barjas-Castro ML. Electrical Properties of RBC membrane and Imunoheamtological Investigation - Review Article -Rev Bras Hematol e Hemot (ABHH ) 33(4):297-301, 2011.

25. Ferreira AA, Zulli R, Soares S, Castro V, Souza HM. Identification of platelet refractoriness in oncohematologic patients. Clinics 66: 35-40, 2011.

26. Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CSPL, De Souza CA, Lorand Metze I, Metze K. Fractal Characteristics of May-Grünwald-Giemsa Stained Chromatin Are Independent Prognostic Factors for Survival in Multiple Myeloma. Plos One 6: 1-8, 2011.

27. Fontes A, Barjas Castro-ML, Brandão MM, Fernandes HP, Thomaz AA, Huruta RR, Pozzo LY, Barbosa LC, Costa FF, Olalla Saad ST, César CL. Mechanical and electrical properties of red blood cells using optical tweezers. Journal of Optics 13: 044012 (8pages), 2011.

28. Francheski DSA, De Souza CA, Aranha FJP, Cardozo DM, Sell AM, Visentainer JEL. Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation. Revista Brasileira de Hematologia e Hemoterapia 33: 126-130, 2011.

29. Franco Cairo JP, Leonardo FC, Alvarez TM, Ribeiro DA, Buchli F, Costa-Leonardo AM, Carazzolle MF, Costa FF, Paes Leme AF, Pereira GA, Squina FM. Functional characterization and target discovery of Glycoside Hydrolases from Lower Termite Coptotermes gestroi Digestome.Biotechnol Biofuels. 4(1):50, 2011.

30. Hamilton A, Ozelo M, Leggo J, Notley C, Brown H, Frontroth JP, Angelillo-Scherrer A, Baghaei F, Enayat SM, Favaloro E, Lillicrap D, Othman M. Frequency of Platelet type versus Type 2B von Willebrand Disease. Thrombosis and Haemostasis 105: 501-508, 2011.

31. Hipsky CH, Costa DC, Omoto R, Zanette A, Castilho L, Reid ME. Prevalence of RHD*DOL and RHCE*ce(818T) in two populations. Immunohematology, 27:66-67, 2011.

32. Horn T, Castilho L, Moulds JM, Billingsley K, Vege S, Johnson N, Westhoff CM. A novel JKA allele, nt561C>A, associated with silencing of Kidd expression. Transfusion, doi:10.1111/j.1537-2995, 2011.

33. Jankowska A; Makishima H; Tiu RV; Szpurka H; HuangY; Traina F; Visconte V; Sugimoto Y; Prince C; O Keefe CL; Hsieh FH; List A; Sekeres M A; Rao A; Mcdevitt M A; Maciejewski JP. Mutational Spectrum Analysis Of Chronic Myelomonocytic Leukemia Includes Genes Associated With Epigenetic Regulation: UTX, EZH2 and DNMT3A. Blood Oct; 118 (14): 3932-3941, 2011.

34. Kantarjian HM, Hochhaus A, Saglio G, De Souza CA, Flinn IW, Stenke L, Goh YT, Rosti G, Nakamae H, Gallagher NJ, Hoenekopp A,Blakesley RE, Larson RA, Hughes TP. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncology 12: 841-851, 2011.

35. Kasahara N, Caixeta-Umbelino C, Paolera MD, Rocha MN, Richeti F, Vasconcellos JP, Cohen R, Costa VP, Longui CA, Melo MR, Melo MB. Myocilin mt.1 gene promoter single nucleotide polymorphism (-1000C>G) in Brazilian patients with primary open angle glaucoma. Ophthalmic Genet, 32:18-23, 2011.

36. Lazarini M, Traina F, Winnischofer SM, Costa FF, Queiroz MLS, Olalla Saad ST. Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: Induction of IL-10 expression in the stromal layers. Leukemia Research, 35:1102-1107, 2011.

37. Leonardo FC, da Cunha AF, da Silva MJ, Carazolle MF, Costa—Leonardo AM, Costa FF, Pereira GA. Analysis of the workers head transcriptome of the Asian subterranean térmite, Coptotermes gestroi. Bull Entomol Res, 101:383-391, 2011.

38. Machado MP, Tomaz JP, Lorand-Metze I, Souza CA, Vigorito AC, Delamain MT, Bendit I, Pereira NF, Pagnano KBB. Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase. Revista Brasileira de Hematologia e Hemoterapia 33: 211-215, 2011.

39. Machado-Neto JA, Favaro P, Lazarini M, Costa FF, Olalla Saad ST Traina F. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochimica et Biophysica Acta, 1813:1404-1411, 2011.

40. Machado-Neto JA, Traina F, Lazarini M, Melo Campos P, Pagnano KBB, Lorand-Metze I, Costa FF, Olalla Saad ST. Screening for hotspot mutations in P13K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes. Clinics 66(5):793-799, 2011.

41. Mali RS, Ramdas B, Ma P, Shi J, Munugalavadla V, Sims E, Wei L, Vemula S, Nabinger SC, Goodwin CB, Chan RJ, Traina F, Visconte V, Tiu RV, Lewis TA, Stern AM, Wen Q, Crispino JD, Boswell HS, Kapur R. Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL. Cancer Cell. Sep; 20(3):357-369, 2011.

42. Martinelli BM, Barjas–Castro ML, Castro V. The frequency of the new platelet antigen Cab in the Brazilian population. Vox Sanguinis100: 343-343, 2011.

43. Matsui H, Hegadorn C, Ozelo M, Burnett E, Tuttle A, Labelle A, McCray PB, Naldini L, Brown B, Hough C,Lillicrap D. A MicroRNA-regulated and GP64-pseudotyped Lentiviral Vector Mediates Stable Expression of FVIII in a Murine Model of Hemophilia A. Molecular Therapy 19: 723-730, 2011.

44. Mawardi H, Elad S, Correa ME, Stevenson K, Woo S-B, Almazrooa S, Haddad R, Antin JH, Soiffer R, Treister N. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplantation 884-891, 2011.

45. Mazzola TN, da Silva MT, Abramczuk BM, Moreno YM, Lima SC, Zorzeto TQ, Passeto AS, Vilela MM. Impaired bacillus Calmette-Guérin cellular immune response in Human Immunodeficiency Virus-exposed, uninfected infants. AIDS. AIDS. 25(17): 2079-2087, 2011.

46 . Menaa F, Braghini CA, Vasconcellos JPC, Menaa B, Costa VP, Figueiredo ES, Melo MB. Keeping an eye on myocilin: a complex molecule associated with primary open-angle glaucoma susceptibility. Molecules 16:5402-5421, 2011.

47. Miguel LI, Almeida CB, Traina F, Canalli AA, Dominical VM, Olalla Saad ST, Costa FF, Conran N. Inhibition of phosphodiesterase 9ª reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals. Inflammation Research, 60:633-642, 2011.

48. Moraes PC, Noce CW, Thomaz LA, Cintra ML, Correa ME. Pigmented lichenoid drug eruption secondary to chloroquine therapy: an unusual presentation in lower lip. Minerva Stomatol. Jun;60(6):327-332, 2011.

49. Moura-Neto JP, Lyra IM, Reis MG, Gonçalves MS. The association of infection and clinical severity in sickle cell anaemia patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 105:121-126, 2011.

50. Nicolini FE, Turkina A, Shen ZX, Gallagher N, Jootar S, Powell BL, De Souza CA, Zheng M, Szczudlo T, le Coutre P. Expanding Nilotinib Access in Clinical Trials (ENACT). Cancer, 2011.

51. Noce CW, Gomes A, Copello A, Barbosa RD, Sant'anna S, Moreira MC, Correa ME, Maiolino A, Torres SR. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent. Nov-Dec;59(6):458-462, 2011.

52. Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, Hadley S, León C, Nucci M, Patterson TF, Perfect JR. Early treatment of candidemia in adults: a review. Med Mycol, 49:113-20, 2011.

53. Pelaquini EH, Guimarães L de A, Benetti LR, Fernandes LG, Tamashiro WM, Conran N, Ferreira HH. Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice. Int Immunopharmacol. 11:204-211, 2011.

54. Pereira CM, Gasparetto PF, Carneiro DS, Corrêa ME, Souza CA. Tooth extraction in patients on oral anticoagulants: prospective study conducted in 108 Brazilian patients. ISRN Dentistry ;2011:203619, 2011.

55. Pereira TC, Saron ML, de Carvalho WA, Vilela MM, Hoehr NF, Hessel G. Research on zinc blood levels and nutritional status in adolescents with autoimmune hepatitis. Arq Gastroenterol. 48(1):62-65, 2011.

56. Perroud Jr MW, Honma HN, Barbeiro AS, Gilli SCO, Almeida MT, Vassallo J, Olalla Saad ST, Zambon L. Mature autologous dendriticcell vaccines in advanced non-small cell lung cancer: a Phase I pilot study. Journal of Experimental & Clinical Research, 30:65-73, 2011.

57. Ramalho LC, Gonçalves EM, de Carvalho WR, Guerra-Junior G, Centeville M, Aoki FH, Morcillo AM, dos Santos Vilela MM, da Silva MT. Abnormalities in body composition and nutritional status in HIV –infected children and adolescents on antiretroviral therapy. Int J STD AIDS. 22(8):453-456,2011.

58. Ruiz MA, De Souza CA. O Desafio de 2011. Revista Brasileira de Hematologia e Hemoterapia 32: 429-429, 2011.

59. Santos FLN, Gonçalves MS, Souza NM. Validation and utilization of PCR for differential diagnosis and prevalence determination of Entamoeba histolytica/Entamoeba dispar in Salvador City, Brazil. The Brazilian Journal of Infectious Diseases 15: 119-125, 2011.

60. Santos JL, Lanaro C, Lima L, Gambero, Alexandre-Moreira MS, Wade M, Yerigenahally S, Kutlar A, Meiler SE, Costa FF, Chung M. Design, synthesis and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. Journal of Medicinal Chemistry, 54:5811-5819, 2011.

61. Santos MN, Bezerra MA, Domingues BL, Zaccariotto T, Oliveira DM, Costa FF, Araújo A, Sonati MF. Haptoglobin genotypes in sickle cell disease. Genet Test Mol Biomarkers, 15: 709-713, 2011.

62. Silveira ZML, Barbosa MV, Fernandes TAAM, Kimura EM, Costa FF, Sonati MF, Rebecchi IMM, Medeiros TMD. Molecular characterization of beta-thalassemia in patientsfrom the state of Rio Grande do Norte, Brazil. Genetics and Molecular Biology 34: 425-428, 2011.

63. Storry J, Castilho L, Daniels G, Flegel W, Garratty G, Francis C, Moulds J, Mouls JJ, Olsson ML, Poole J, Reid M, Rouger P, Scott M, Smart E, Tani Y, Wendels S, Westoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sanguinis (Basel. 1956)  101: 77, 2011.

64. Suemasu CN, Kimura EM, Oliveira DM, Bezerra MAC, Araujo AS, Costa FF, Sonati MF. Characterization of alpha thalassemicgenotypes by multiplex ligation-dependent probe amplification in the Brazilian population. Braz J Med Biol Res, 44:16-22, 2011.

65. Tarazona-Santos E, Castilho L, Amaral DR, Costa DC, Furlan NG, Zucherato LW, Machado M, Reid M, Zalis M, Rossit A, Santos S, Machado RD, Lustigman S. Population Genetics of GYPB and Association Study between GYPB*S/s Polymorphism and Susceptibility to P. falciparum Infection in the Brazilian Amazon. Plos One 6: e16123, 2011.

66. Thomas S, Gabriel MB, Assi PE, Barboza M, Perri ML, Land MG, Da Costa ES; Brazilian Hemophilia Centers. Radioactive synovectomy with Yttrium⁹⁰ citrate in haemophilic synovitis: Brazilian experience.Haemophilia, 17:e211-216, 2011.

67. Tiu RV, Traina F, Sekeres MA. Clofarabine for myelodysplastic syndromes. Expert Opinion on Investigational Drugs 20:1005-1014, 2011.

68. Tiu RV, Visconte V, Traina F,  Schwandt A, Maciejewski JP. Updates in Cytogenetics and Molecular Markers in MDS. Current Hematologic Malignancy Reports 6:126-135, 2011.

69. Tiu RV, Visconte V, Traina F, Schwandt A, Maciejewski JP. Updates in cytogenetics and molecular markers in MDS. Curr Hematol Malig Rep. Jun;6(2):126-35, 2011.

70 . Vancine SMC, Picoli-Quaino SK, Costa DSP, Montalvão SAL, Ozelo MC, Annichino-Bizzacchi JM, De Paula EV. Severe VIII and factor IX deficiencies are compatible with normal survival in a mouse endotoxemia model. Haemophilia, 17(5): 800-807, 2011.

71. Vancine SMC, Picoli-Quaino SK, Costa DSP, Montalvão SAL, Ozelo MC, Annichino-Bizzacchi JM, De Paula EV. Evaluation of the host response to endotoxemia of FVIII and FIX deficient mice. Haemophilia,17:800-807, 2011.

72. Vido JR, Adam RL, Lorand-Metze IGH, Metze K. Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes. Diagnostic Pathology 6:93, 2011.

73. Vigorito AC, Bouzas LFS, Moreira MCR, Funke VAM, Colturato VAR, Souza CV, Nunes EC, Miranda ECM, Camacho K, Mauad MA, Correa MEP, Silva M, Sousa MP, Tavares RC Lee SJ, Flowers MED. A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria. Revista Brasileira de Hematologia e Hemoterapia 33:283-289, 2011.

74. Wobeto VP, Pinho PD, Souza JR, Zaccariotto TR, Sonati MF. Haptoblobin genotypes and refractory hypertension in type 2 diabetes mellitus patients. Arquivos Brasileiros de Cardiologia, 97:338-345, 2011.

75. Zanette AMD, Goncalves MS, Bahia RCS, Nogueira LAV, Arruda S. Sickle cell anemia: delayed diagnosis in Bahia, Brazil- a largely Afro-descendant population. Ethnicity & Disease 21: 243-247, 2011.

 

2010

1 –         Alves BF, Montalvão SA, Aranha FJ, Siegl TF, Souza CA, Lorand Metze I, Annichino–Bizzacchi JM, De Paula EV. Imbalances in serum angiopoietin concentrationas are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia.  BMC Infect Dis, 10:143, 2010.

2 –         Andrade T, Moreira L, Duarte A, Lanaro C, Albuquerque D, Olalla-Saad ST, Costa FF. Expression of new red cell-related genes in erytrhoid differentiation. Biochem Genet 48:164-171, 2010.

3 –         Bagarolli RA, Saad MJA, Olalla-Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphism are associated with Type 2 diabetes. J Diabetes Complications 24:192-198, 2010.

4 –         BarattiMO, Morira YB, Traina F, Costa FF, Verjovski-Almeida S, Olalla-Saad ST. Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts. BMC Med Genomics 3:30-45, 2010.

5 –         Barbosa CG,  Goncalves-Santos NJ, Moura-Netto JP, Ribeiro SBS, Takahashi D, Reis MG, Gonçalves MS. Promoter region sequence differences in the A and G gamma globin genes of Brazilian sickle cell anemia patients. Braz J Med Biol Res 43:705-711, 2010.

6 –         Benites BD, Traina F, Duarte ASS, Lorand Metze IGH, Costa FF, Olalla Saad ST. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia. Eur J Haematol 84:525-530, 2010.

7 –         Bordeaux-Rego P, Luzo AC, Costa FF, Olalla-Saad ST, Crosara Alberto DP. Both IL-3 and IL-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Stem Cells Dev, 19:413-421, 2010.

8 –         Cortes J, De Souza C, Ayala-Sanchez M, Bendit I, Best-Aguilera C, Enrico A, Hamerschlak N, Pagnano K, Pasquini R, Meillon L. Current patient  management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET). Cancer 116(21):4991-5000, 2010.

9 –         Cortes JE, M Baccarani, F Guilhot, B Druker, S Branford, DW Kim, F Pane, R Pasquini, S Goldberg, M Kalaycio, B Moiraghi, J Rowe, E Tothova, J Waselenko, De Souza CA, M Rudoltz, R Yu, T Krahnke, HP Kantarjian, JP Radich, TP Hughes. Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg of imatinib mesylate with in patients newly disgnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular endpoints – TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) Study. J Clin Oncol 3: 424-430, 2010.

10 –      Da Cunha AF, Brugnerotto AF, Duarte AS, Lanaro C, Costa GG, Olalla-Saad ST, Costa FF. Global gene expression reveals a set of new genes involved in the modification of cells during erythroid differentiation. Cell Prolif 43:297-309, 2010.

11 –      Da Luz, Kimura EM, Costa FF, Sonati MF, Sans M. Beta-Globin gene cluster haplotypes in Afro-Uruguayans from two geographical regions (South and North).  Amer J Hum Biol 22:124-128, 2010.

12 –      Denomme GA, Westhoff CM, Castilho LM, St-Louis M, Castro V, Reid ME. Consortium for blood group genes (CBGG): 2009 report. Immunohematology 26:47-50, 2010.

13 –      Fernandes TAR, R Fukai, De Souza CA, Lorand-Metze I, LA Magna, MHS Kraemer. Molecular Indentification of The HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias. Blood Cells Mol Dis 44(2):69-73, 2010.

14 –      FertrinKY, Costa FF. Genomic polymorphisms in sickle cell disease: Implications for clinical diversity and treatment. Expert Rev Hematol 3(4):443-458, 2010.

15 –      Jorge SE, Abreu CF, Guariento ME, Sonati MF. Haptoglobin genotypes in Chagas' disease. Clin Biochem 43(3):314-316, 2010.

16 –      Magalhães RF, Cintra ML, Barjas-Castro ML, Del Negro GM, Okay TS, Velho PE.Blood donor infected by Bartonella hansele. Transfus Med 20(4):280-282, 2010.

17 –      Mara CS, Duarte AS, Sartori A, Luzo AC, Olalla-Saad ST, Coimbra IB. Regulation of chondrogenesis by transforming growth factor {beta}3 and insulin-like growth factor-1 from human mesenchymal umbilical cord blood cells. J Rheumatol, 37(7):1519-1526, 2010.

18 –      Marques Jr JFC. Editorial: Condutas frente à contaminação bacteriana em concentrados de células progenitoras hemopoéticas periféricas. Rev Bras Hematol Hemoter 32: 5-6, 2010.

19 –      Mazetto BM, Andrade-Orsa FL, Siqueira LH, Mello TB, De Paula EV, Annichino-Bizzacchi JM. Prevalence of Factor IX-R338L (Factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels. Thromb Res 126(2):e165, 2010

20 –      Mello TB, Orsi FL, Montalvao SA, Ozelo MC, de Paula EV, Annichinno-Bizzachi JM. Long-term prospective study of recurrent venous thromboembolism in a hispanic population. Blood Coagul Fibrinolysis 21(7):660-665, 2010.

21 –      Mezzacappa MA, Facchini FP, Pinto AC, Cassone AL, Souza DS, Bezerra MA, Albuquqerque DM, Olalla- Saad ST, Costa FF. Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants. J Perinatol 30(12):819-826, 2010.

22 –      Moritz E, Chiba AK, Kimura EY, Albuquqerque D, Guirão FP, Yamamoto M, Costa FF, Bordin JO. Molecular studies reveal that A134T, G156A and G1333A SNPs in the CD177 gene are associated with atypical expression of human neutrophil antigen-2. Vox Sang 98(2):160-166, 2010.

23 –      Nomura ML, Couto E, Martinelli BM, Barjas-Castro ML, Barini R, Passini Júnior R, Castro V. Fetal genotyping  for platelets antigens : A precise tool for alloimmune  trombocytopenia: a case report and literature review. Arch Gynecol Obstet 282(5):573-575, 2010.

24 –      Olalla-Saad ST. Fermented papaya preparation for beta thalassemia. Expert Rev Hematol  3(3):265-268, 2010.

25 –      Orsi FA, Annichino-Bizzacchi JM, de Paula PV, Ozelo MC, Langley MR, Weck KE. VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy. Thromb Res 126(3):e206-210, 2010.

26 –      Pagnano KB, de Carvalho Duarte G, Lorand-Metze I, Delamain MT, Miranda EC, De Souza CA Treatment outcome of acute promyelocytic leukemia with modified aida protocol. Adv Hematol. 2010; 2010:672137.

27 –      Pelegrine AA, da Costa CES, Correa MEP, Marques Jr JF. Clinical and histomorphometric evaluation of extraction sockets treated with an autologous bone marrow graft. Clin Oral Implants Res 21: 535-542, 2010.

28 –      Proença-Ferreira R, Franco-Penteado CF, Traina F, Olalla-Saad ST, Costa FF, Conran N. Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIbbeta3-mediates ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity. Br J Haematol 149(2):280-288, 2010.

29 –      Reis–Alves SC, Traina F, Olalla-Saad ST, Metze K, Lorand-Metze I. The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes. Neoplasma 57(6):530-536, 2010.

30 –      Rossi FC, Angerami RN, de Paula EV, Orsi FL, Shang D, del Guercio VM, Resende MR, Annichino-Bizzacchi JM, da Silva LJ, Zheng X, Long A, Castro V. A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection. Transfusion 50:208 - 212, 2010.

31 –      Souza DS, Spencer DM, Salles TSI, Salomão MA, Payen E, Beuzard Y, Carvalho HF, Costa FF, Olalla-Saad ST. Death switch for gene therapy: application to erythropoietin transgene expression. Braz J Med Biol Res, 43(7):634-644, 2010.

32 –      Walter EC, Orozco-Levi M, Ramirez-Sarmiento A, Vigorito AC, Campregher PV, Martin PJ, Flowers ME, Chien JW. Lung Function an Long-Term complications after Allogeneic Hematopoietic Cell Transplant. Biol Blood Marrow Transplant 16:53-61, 2010

33 –      Xavier JM, Costa FF, Annichino-Bizzacchi JM, Olalla-Saad ST. High frequency of vitamin B12 deficiency in a Brazilian population. Public Health Nutr, 13:1191-1197, 2010.

34 –      Zanette AMD, Gonçalves MS, Schettini LV, Aguiar LM, Bahia RCS, Brandão  JFB, Azevedo CAN, Aragao LR, Arruda SM. Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethn Dis 20:136-141, 2010.

 

2009

1 –         Almeida AC, Barbosa SM, Barjas-Castro MLD, Olalla-Saad ST, Condino-Neto A. The role of glucocorticoid in SIRPalpha and SHP-1 gene expression in AIHA patients. Immunopharmacology and Immunotoxicology 31(4):636-640, 2009.

2 –         Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C, Hughes TP, Erben P, Van Tornout J, Stone RM. Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial. J Clin Oncol 27(21):3472-3479, 2009.

3 –         Basso FG, Boer CC, Corrêa ME, Torrezan M, Cintra ML, de Magalhães MH, da Silva Santos P, de Souza CA. Skin and oral lesions associated to imatinib mesylate therapy. Support Care Cancer. 17: 465-468, 2009.

4 –         Betts RF, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JA, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, Kartsonis NA; Caspofungin High-Dose Study Group. A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.Clin Infect Dis 48(12):1676-84, 2009.

5 –         Bezerra MAC, Albuquerque DM, Santos MNN, Kimura EM, Jorge SEDC, Oliveira DM, Domingues BLTB, Peres JC, Araujo AS, Costa FF, Sonati MF. Two unstable haemoglobins leading to chronic haemolytic anaemia: HbCaruaru [beta122 (GH5) Phe to Ser], a probable case of germ line mutation, and Hb Olinda [beta 22 (B4) – 25 (B7)], a deletion of a 12 base-pair sequence. European Journal of Haematology, 83:378-382, 2009.

6 –         Bigarella CL, Borges L, Costa FF, Saad STO. ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration. Biochim Biophys Acta 1793:806-816, 2009.

7 –         Boer CC, Correa MEP, Miranda, E C M, De Souza CA. Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplantation (Basingstoke). 1 - 7, 2009.

8 –         Brandão MM, Castro ML, Fontes A, Cesar CL, Costa FF, Saad STO. Impaired red cell deformability in iron deficient subjects. Clin Hemorheol Microcirc 43(3):219-223, 2009.

9 –         Castilho L. Co-autoria no Standards e Guidance  for Molecular Testing for Prediction of Red Cell, Platelet, and Neutrophil Antigens, 1st edition (publicado pela AABB em 2009)

10 –      Castro V. O papel do voto de autoexclusão na segurança transfusional. Revista Brasileira de Hematologia e Hemoterapia 31.213 - 214, 2009.

11 –      Chiattone CS, JPM Pereira, DM Langhi Júnior, MA Rugani, De Souza CA, JCP Saraiva, SB Mesiano. Carta ao Editor: Urgência na introdução do NAT: é fundamental não cometer os erros do passado. Rev Bras Hematol Hemoter, 31 (2): 113-114, 2009.

12 –      Claudino MA, Franco-Penteado CF, Corat MAF, Gimenes AP, Passos LAC, Antunes E, Costa FF. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med, 6(8):2187-96. 2009.

13 –      Conran N, Costa FF. Hemoglobin disorders and endothelial cell interactions. Clin Biochem, 42:1824-1838, 2009.

14 –      Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 33:01-16, 2009.

15 –      Cunha AF, Brugnerotto AF, Finzi Corat MA, Devlin EE, Gimenes AP, Barbosa de Melo M, Corrêa Passos LA, Bodine D, Olalla-Saad ST, Costa FF. High levels of human gamma-globin are expressed in adult mice carrying a transgene of the Brazilian type of hereditary persistence of fetal hemoglobin ((A) gamma -195). Hemoglobin 33:439-447, 2009.

16 –      Da Costa Reis Monte-Mór B, Plo I, da Cunha AF, Costa GG, de Albuquerque DM, Jedidi A, Villeval JL, Badaoui S, Lorand-Metze I, Pagnano KB, Olalla-Saad ST, Vainchenker W, Costa FF. Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage. Leukemia. 23(1):144-52, 2009.

17 –      Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke M, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Sistonen P, Smart E, Storry JR., Tani Y, Yu L-C, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Committee on Terminology for Red Blood Cell Surface Antigens: Macao report Vox Sang 96: 153-156, 2009

18 –      De Paula EV, Flores-Nascimento MC, Arruda VR, Garcia RA, Ramos CD, Guillaumon AT, Annichino-Bizzacchi JM. Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia. Transl Res 153(5):232-239, 2009.

19 –      De Paula EV, Montalvao SA, Madureira PR, Jose Vieira R, Annichino-Bizzacchi JM, Ozelo MC. Simultaneous bleeding and thrombosis in superwarfarin poisoning. Thromb Res 123(4):637-639, 2009.

20 –      De Paula EV, Ozelo MC. Pharmacoeconomic studies of bypassing agents in mild-to-moderate bleeding episodes in patients with hemophilia and inhibitors: a critical appraisal. Journal of Coagulation Disorders 1 (1):93-97, 2009.

21 –      De Souza CA, Pagnano KBB, Lorand-Metze I, Miranda ECM, Baldissera R, Aranha FJP, Vigorito AC, Duarte BKL. Brazilian experience using high-dose sequential therapy (HDS) followed by autologous hematopoietic stem cell transplantation (ASCT) for malignant lymphoma. Rev Bras Hematol Hemoter 31(2): 9-14, 2009.

22 –      Denomme G, Westhoff C, Castilho L. Reid M, Consortium for blood group genes (CBGG): 2008 report. Immunohematology,25:75-80, 2009

23 –      Duarte BK, Valente I, Vigorito AC, Aranha FJP, Duarte GO, Miranda ECM, Lorand-Metze I, Pagnano KB, Delamain M, Junior JF, Brandalise SR, Nucci M. Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory hodgkin lymphoma. Clin Lymphoma Myeloma 9(6):449-454, 2009.

24 –      Faber EW, Lourenço GJ, Ortega MM, Silva PMR, De Souza CA, Lorand-Metze I, Lima CSP. The angiogenesis-related polymorphisms: roles for the risk of multiple myeloma. EJC Supplements 7(2):569-570, 2009.

25 –      Flores-Nascimento MC, Beltrame MP, De Paula EV, Montalvão SL, Orsi FLA, Lorand-Metze I, Annichino-Bizzacchi JM. Microparticles in Deep Venous Trombosis, Antiphospholiped Syndrome and Factor V Leiden. Platelets 20(6):367-375, 2009.

26 –      Garnica M, Maiolino A, Nucci M. Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients.Braz J Med Biol Res 42(3):289-293, 2009.

27 –      Garnica M, Nucci M, Queiroz-Telles F Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis.Curr Opin Infect Dis. 22(6):559-563, 2009.

28 –      Gonçalves MS, Moura Neto JP, CL S, Melo P, Reis MG. Evaluating glutathione S-Transferase (GST) null genotypes (GSTT1 and GSTM1) as a potential biomarker of predisposition for developing leukopenia. International Journal of Laboratory Hematology 32:49-56, 2009

29 –      Halverson GR,  Tossas E, Velliquette RW, Lobo C,  Reid ME, Frame T,  Castilho L, Lee AH,  Storry JR, Grodecka M, Waśniowska K,  Duk M, Lisowska E. Murine monoclonal anti-s and other anti-glycophorin B antibodies resulting from immunizations with a GPB.s peptide. Transfusion 49:485-494, 2009

30 –      Kimura EM, Oliveira DM, Fertrin K, Pinheiro VRV, Jorge SE, Costa FF, Sonati MF. Hb H Disease resulting from the association of an alpha0-thalassemia allele [-(a)20.5] with an unstable alpha-globin variant [Hb Icaria]: first report in the Brazilian population. Genet Mol Biol 32: 712-715, 2009.

31 –      Lanaro C, Franco-Penteado CF, Albuquerque DM, Saad STO, Conran N, Costa FF. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 85,(2):235-242, 2009.

32 –      Lima CSP, Lourenço GJ, Lorand-Metze I, Nascimento H, Saad STO, Costa FF. No contribution of GSTM1 and GSTT1 null genotypes to the risk of neutropenia due to benzene exposure in Souteastern Brazil.  Genet Mol Biol 32: 709-711, 2009.

33 –      Lomas-Francis C,  Alcantara D, Westhoff C,  Uehlinger J, Valvasori M,  Castilho L, Reid ME. JAL (RH48) blood group antigen: serologic observations  Transfusion. 49:719-724, 2009

34 –      Lourenço GJ, Néri IA, Sforni VCS, Kameo R, Lorand-Metze I, Lima CSP. Polymorphisms of glutathione S-transferase Mu 1, glutathione S-transferase theta 1 and glutathione S-transferase Pi 1 genes in Hodgkin's lymphoma susceptibility and progression. Leuk Lymphoma  50 (6): 1005–1009: 2009.

35 –      Luzo ACM. FB Pereira, RC de Oliveira, PR Azevedo, RD Cunha, MI Leonardi, LS Leonardi, AR Cardoso, CA Caruy, EC Ataíde, IFSF Boin. Red Blood Cell Antigen Alloimmunization in Liver Transplant Recipients. Transplant Proc 42: 494-495, 2010.

36 –      Magalhaes RF, Urso Pitassi lH, Lania BG, Barjas-Castro ML, Neves Ferreira Velho PE Bartonellosis as cause of death after red blood cell unit transfusion. Ultrastruct Pathol  33(4):151-154, 2009

37 –      Maluf E, Hamerschlak N, Cavalcanti AB, Avezum Júnior A, Eluf-Neto J, Falcão RP, Lorand-Metze I, Goldenberg D, Santana CL, Rodrigues DOW, Passos LNM, Rosenfeld LGM, Pitta M,  Loggetto S, Ribeiro AAF, Velloso ED, Kondo AT, Coelho EOM, Pintão MCT, Souza HM, Borbolla JR, Pasquini R. Incidence and risk factors of aplastic anemia in Latin American countries: The LATIN case-control study. Haematologica 94:1220-1226, 2009.

38 –      Marques Junior JFC. Aféresis Terapéuticas In: VII Congreso de la Asociación Mexicana de Medicina Transfusional, A.C., 2009, Tuxtla Gutierrez – Chiapas - Revista Mexicana de Medicina Transfusional. Ciudad de Mexico: Medigraphic – Artemisa 2:S24 - S26, 2009.

39 –      Mascarenhas CC, Cunha AF, Miranda EC, Zulli R, Silveira RA, Costa FF, Pagnano KB, De Souza CA. New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Leuk Lymphoma 50(7):1148-1154, 2009.

40 –      Mello TB, Machado TF, Montavão SA, Ozello MC, Annichino-Bizzacchi JM. Assessing the Coagulation Factor Levels, Inherited Thrombophilia, and ABO Blood Group on the Risk for Venous Thrombosis Among Brazilians. Clin Appl Thromb Hemost. Aug; 15 (04):408-414, 2009.

41 –      Moraes PC, Noce CW, Thomas, L A, Mantoni, MC, Correa, ME. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. J Am Dent Assoc (1939) 140:1377 - 1379, 2009

42 –      Mota M, Bley C, Aravechia MG, Hamershlak N, Sakashita A, Kutner JM, Castilho L. Autoantibody formation after alloimmunization inducing bystander immune hemolysis. Immunohematology 25: 9-12, 2009.

43 –      Omoto R, Reid M, Castilho L. Molecular analyses of GYPB in African Brazilians. Immunohematology, 24:148-153,2009

44 –      Pfeifer WP, Degasperi GR, Almeida MT, Vercesi AE, Costa FF, Saad STO. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia. Acta Haematol 120:225-231, 2009.

45 –      Reis SC, Traina F, Metze K, Saad STO, Lorand-Metze I. Variation of bone marrow cd 34+ cell subsets in myelodysplastic syndromes according to WHO types. Neoplasma 56(5):435-440, 2009.

46 –      Ribeiro DM, Zaccariotto TR, Santos MNN, Costa FF, Sonati MF. Influence of the polymorphisms of the alpha-major regulatory element HS-40 on in vitro gene expression. Braz J Med Biol Res 42:776-869, 2009.

47 –      Ribeiro KR, Guarnieri MH, Da Costa DC, Costa FF, Pellegrino Jr J, Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood patients with sickle cell disease. Vox Sang, 97:147-152, 2009.

48 –      Santos A, Annichino-Bizzacchi JM, Ozelo MC. Inhibitors of factor VIII in hemophilia.  N Engl J Med. 61(3):309-310, 2009.

49 –      van der Schoot CE, de Haas M, Engelfriet CP, Reesink HW, Panzer S, Jungbauer C, Schwartz DMW, Mayr WR, Castilho L, St-Louis M, Long A, Denomme G, Semple E, Fernandes B, Flegel WA, Wagner F, Doescher A, Poli F, Villa MA, Paccapelo C, Karpasitou K, Veldhuisen B, Nogués N, Muñiz-Diaz E, Daniels G, Martin P, Finning K, Reid ME. Genotyping for red blood cell polymorphisms. Vox Sang 96: 167-179, 2009

50 –      Vigorito AC, CA De Souza. Artigo Especial: Transplante de células-tronco hematopoiéticas e a regeneração da hematopoiese. Rev Bras Hematol Hemoter, 31(4): 2009.

51 –      Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HPK, Fero ML, Warren EH, Lee SJ, Appelbaum FR, Martin PJ, Flowers MED. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 114:702-708, 2009.

52 –      Wenning MR, Mello MP, Andrade TG, Lanaro C, Albuquerque DM, Saad STO, Costa FF, Sonati MF. PIP4KIIA and beta-globin: Transcripts differentially expressed in reticulocytes and associated with high levels of Hb H in two siblings with Hb H disease. Eur J Haematol, 83(5):490-493, 2009.

53 –      Wobeto VPA, Garcia PMD, Zaccariotto TR,Sonati MF. Haptoglobin polymorphism and diabetic nephropathy in Brazilian diabetic patients. Ann Hum Biol 36:437-441, 2009.

54 –      Yamaguti GG, Lourenço GJ, Costa FF, Lima CSP. High risk of ‘de novo’ acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects. Eur J Hematol 83(3):270-272, 2009.

 

Buy cheap web hosting service where fatcow web hosting review will give you advices and please read bluehost review for more hosting information.